DB05839ExperimentalSmall molecule
BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical studies.
- Mechanism
- Curator reviewed
BG-777 will activate the cells of the immune system and improve its ability to clear the virus, and resist infection.
- Primary indication
- Investigated for use/treatment in cytomegalovirus (CMV) retinitis, HIV infection, influenza, and pneumonia.Curator reviewed
- Code names
- BG-777
Which companies are running trials of BG-777, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account